Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
about
Interferon Beta for Primary Progressive Multiple SclerosisMultiple sclerosisNew and emerging immune-targeted drugs for the treatment of multiple sclerosisPermeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosisRisk Factors for Poor Adherence to Betaferon® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeTreatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.Disease-modifying therapies in relapsing-remitting multiple sclerosis.Impact of pregabalin treatment on synaptic plasticity and glial reactivity during the course of experimental autoimmune encephalomyelitis.Evolving expectations around early management of multiple sclerosis.Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?Neurodegenerative disorders and nanoformulated drug development.Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosisDisease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.Prognostic Factors of MS Conversion in Optic Neuritis.Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology.Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.Optic neuritis in Hong Kong: a 1-year follow-up study.Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis.
P2860
Q24240620-FFA00485-4815-41D3-85E4-567628EFFBF2Q26995437-A51EE320-761B-4A09-8C1F-8A83D1D4B105Q26997067-1402EABB-6789-4E6A-8854-0BF727CA0B65Q28265269-19BE83B6-BD0D-421A-8A11-302B4D761ADDQ28554434-594F1C2E-27CD-439C-9D41-B7206B7B13E9Q30234672-D51ADB63-0ACD-4FCE-9554-1A9A3ECAAE7DQ34122924-FDC313E0-BEE1-4CB9-A9D6-908FFC398155Q34259055-FA7174C3-2DDE-453B-AC66-55AF9C6CAECAQ34409412-32EA8D8C-B4D7-4E07-81FC-ECDDD58148E7Q35588410-9FD4FD6F-0BBF-4E4A-B324-40F0522C833DQ35598871-2C87E3B2-1FE0-4766-9558-BF98C1235319Q37538771-B45883A1-A2EE-4FF2-9B15-9E0EA15BFCF3Q38070677-15D5BF68-C6DA-46C3-8C73-3178CD4E74DAQ38137114-30526B79-55FE-4323-A211-A461B50B75F1Q38313788-18F941C7-08AF-4050-902B-1CFF5A33CA5AQ39093778-8AC66241-1F40-4BD3-AF6D-AAE35604C3FDQ41985907-758D37F6-CD07-4C19-B8BD-C26B0BAC69CAQ43691209-80BD6A14-FE1C-443A-9D6D-C250D59E4DE4Q47719573-9353FB98-D06E-4105-9C49-08B3404FDBAE
P2860
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
description
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2008/04/23)
@fr
articolo scientifico (pubblicato il 2008/04/23)
@it
artigo científico (publicado na 2008/04/23)
@pt
artikull shkencor
@sq
artículu científicu espublizáu en 2008
@ast
scientific article (publication date: 23 April 2008)
@en
vedecký článok (publikovaný 2008/04/23)
@sk
videnskabelig artikel (udgivet 2008/04/23)
@da
name
Recombinant interferon beta or ...... ng event to multiple sclerosis
@ast
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en-gb
Recombinant interferon beta or ...... ng event to multiple sclerosis
@nl
type
label
Recombinant interferon beta or ...... ng event to multiple sclerosis
@ast
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en-gb
Recombinant interferon beta or ...... ng event to multiple sclerosis
@nl
prefLabel
Recombinant interferon beta or ...... ng event to multiple sclerosis
@ast
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en-gb
Recombinant interferon beta or ...... ng event to multiple sclerosis
@nl
P2093
P2860
P3181
P1476
Recombinant interferon beta or ...... ng event to multiple sclerosis
@en
P2093
P2860
P304
P3181
P356
10.1002/14651858.CD005278.PUB3
P50
P577
2008-04-16T00:00:00Z